标题
MET in gastric cancer - discarding a 10% cutoff rule
作者
关键词
-
出版物
HISTOPATHOLOGY
Volume 68, Issue 2, Pages 241-253
出版商
Wiley
发表日期
2015-05-28
DOI
10.1111/his.12745
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development
- (2015) Stephen P. Hack et al. Oncotarget
- MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit
- (2015) Denis L. Fontes Jardim et al. Oncotarget
- Prognostic Impact of Major Receptor Tyrosine Kinase Expression in Gastric Cancer
- (2014) Yukinori Kurokawa et al. ANNALS OF SURGICAL ONCOLOGY
- HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma
- (2014) Y J Liu et al. BRITISH JOURNAL OF CANCER
- Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma
- (2014) Akiko Kawano Nagatsuma et al. Gastric Cancer
- HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: A distinct subset of patients for dual inhibition therapy
- (2014) Sang Yun Ha et al. INTERNATIONAL JOURNAL OF CANCER
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
- (2014) Kai Wang et al. NATURE GENETICS
- Targeting receptor tyrosine kinases in gastric cancer
- (2014) Asahiro Morishita WORLD JOURNAL OF GASTROENTEROLOGY
- Reproducibility of Her2/neu scoring in gastric cancer and assessment of the 10% cut-off rule
- (2014) Hans-Michael Behrens et al. Cancer Medicine
- Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study
- (2013) S. Watson et al. ANNALS OF ONCOLOGY
- Expression of MACC1 and c-Met in human gastric cancer and its clinical significance
- (2013) Tiankang Guo et al. Cancer Cell International
- Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine
- (2013) Viktoria S. Warneke et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer
- (2013) Yoon-Koo Kang et al. INVESTIGATIONAL NEW DRUGS
- MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas
- (2013) Sang Y Ha et al. MODERN PATHOLOGY
- Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
- (2013) Manish A. Shah et al. PLoS One
- FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation
- (2013) Guy Betts et al. VIRCHOWS ARCHIV
- MET: A Critical Player in Tumorigenesis and Therapeutic Target
- (2013) C. R. Graveel et al. Cold Spring Harbor Perspectives in Biology
- Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
- (2012) V. S. Warneke et al. ANNALS OF ONCOLOGY
- MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome
- (2012) H E Lee et al. BRITISH JOURNAL OF CANCER
- A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
- (2012) Niantao Deng et al. GUT
- Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma
- (2012) Yin Li et al. JOURNAL OF SURGICAL ONCOLOGY
- RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
- (2011) Daniel V.T. Catenacci et al. CANCER BIOLOGY & THERAPY
- Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer
- (2011) Yuji Toiyama et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic Activation of theMETPathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
- (2011) Francesco Graziano et al. JOURNAL OF CLINICAL ONCOLOGY
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
- (2010) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma
- (2010) Tsutomu Namikawa WORLD JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now